Sign in
Active, not recruitingNo phase

Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND

Key facts

Who runs it
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
210 people, planned
Started
25 Sept 2024
Expected to end
Dec 2026
Type of study
Observational, 2 groups
Record updated
28 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patient aged 18 years or older
  • First diagnosis of uni-focal meningioma of the convexity
  • Macroscopical total resection (Simpson 1-3); (Retrospective only):
  • Surgery performed between 2007 and 2016
  • availability of FFPE sample and medical records

Who cannot take part

  • Previous surgical/medical treatment for another meningioma
  • Genetic syndromes
  • positive oncological history (e.g., breast cancer)
  • Diffuse Meningeal Meningiomatosis
  • Patients who underwent experimental treatment in neo-adjuvant setting; (Prospective only):

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Meningiomas are the most common primary intracranial tumors. Current treatment relies on surgical resection and radiotherapy, but molecular predictors for recurrence are lacking. This study aims to investigate epigenetic features, specifically histone post-translational modifications (PTMs) and DNA methylation, to stratify patients. The study involves a retrospective cohort to define an epigenetic signature and a prospective cohort to validate it in tissues and liquid biopsies (plasma/EVs).

The 2 groups in the trial

  • Retrospective Cohort

    150 patients operated for non-recurrent meningioma between 2008 and 2016.

  • Prospective Cohort

    60 patients diagnosed with meningioma recruited prospectively.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients
Record updated
28 August 2026